Chemical Structure (Calcipotriene 01)
Calcipotriene And Betamethasone Dipropionate Suspension
Product Images NDC 51672-1402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Calcipotriene And Betamethasone Dipropionate (NDC 51672-1402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Calcipotriene 02)
Figure A (Calcipotriene 03)
Figure B (Calcipotriene 04)
Figure C (Calcipotriene 05)
Figure D (Calcipotriene 06)
Principal Display Panel (60 g Bottle Carton)
This is a description of a topical suspension for external use only. The suspension contains calcipotriene and betamethasone dipropionate. The product is packaged in a 60g container and the label contains pertinent information such as the NET weight, manufacturers' details, as well as instructions for use. It also includes a reminder to keep the medication out of reach of children. The product instructions advise that the suspension should be shaken prior to use. Rx only notation is included on the label.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
